The application of more biologically active molecules such as alendronic acid, prostacyclin, or insulin-like growth factor 1 (IGF1) can address impaired healing associated with osteoporosis and diabetes in aged patients [45,46,47,48,49,50]. Here, IGF1 is linked to diabetes mellitus.